Ischaemic heart disease

Citations 1-10 of 242 total displayed.

Therapeutics
Intensive and standard glucose control did not differ for CV events or death in poorly controlled type 2 diabetes

Gillian L Booth
Evid Based Med 2009; 14: 73. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD

Matthew B Stanbrook
Evid Based Med 2009; 14: 42-43. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Tiotropium reduced exacerbations but not rate of FEV₁ decline in patients with COPD using other respiratory medications

Evid Based Med 2009; 14: 43. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent stroke

Michael A Sloan
Evid Based Med 2009; 14: 46-47. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Telmisartan did not prevent recurrent stroke or major cardiovascular events

Evid Based Med 2009; 14: 47. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Rosuvastatin prevented major cardiovascular events in people with elevated C-reactive protein

Denise L Campbell-Scherer and Victor M Montori
Evid Based Med 2009; 14: 48. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years

Eoin P O'Sullivan and Sean F Dinneen
Evid Based Med 2009; 14: 9-10. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Benefits of tight blood pressure control to prevent diabetes complications were not sustained

Evid Based Med 2009; 14: 10. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes

Arsh K Jain and Matthew A Weir
Evid Based Med 2009; 14: 11. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: postmenopausal hormone therapy increases risk of stroke and venous thromboembolism but not coronary heart disease events

Angela M Cheung
Evid Based Med 2009; 14: 18. [Extract] [Full text] [PDF] [Request Permissions]